Cargando…
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
BACKGROUND: Persistent infection with high-risk Human papillomaviruses (HPV), such as hr-HPV-16 and hr-HPV-18, lead to cervical cancer, the fourth most common cancer in the world. In the present study, we investigated the alteration of E6 oncogene expression by E6-specific short interfering RNA (siR...
Autores principales: | Shiri Aghbash, Parisa, Hemmat, Nima, Baradaran, Behzad, Bannazadeh Baghi, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862546/ https://www.ncbi.nlm.nih.gov/pubmed/36681850 http://dx.doi.org/10.1186/s40001-023-01014-9 |
Ejemplares similares
-
Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022) -
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
por: AGHBASH, PARISA SHIRI, et al.
Publicado: (2023) -
Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer
por: HEMMAT, NIMA, et al.
Publicado: (2022) -
The role of antigen-presenting cells in the pathogenesis of COVID-19
por: Farzi, Rana, et al.
Publicado: (2022) -
Molecular pathways in the development of HPV-induced cervical cancer
por: Rasi Bonab, Farnaz, et al.
Publicado: (2021)